Table 4.
Proteins interacting with miR-192 in different cancer types.
| Prognosis | Cancer type | miR-192-related regulatory proteins | References |
|---|---|---|---|
| Positive | Breast cancer | BMP-6/miR-192/caveolin 1 | [12, 36] |
| ALL | miR-192/P53, BAX, CASP3 | [34] | |
| OS | miR-192/USP1, TCF7, XIAP | [35, 37, 38] | |
| Colon cancer | miR-192/SRPX2, Rab-2A, RhoA-ROCK-LIMK2, farnesoid X receptor, RB1-E2F1, NOD2 | [39–44] | |
| HCC | miR-192/SLC39A6-SNAIL | [29] | |
| BC | miR-192/transcription factor Yin Yang 1 | [45] | |
|
| |||
| Negative | NB | miR-192/Dicer1 | [8] |
| GC | miR-192/RAB11-FIP2, SMG-1 | [46, 47] | |
| NSCLC | miR-192/FGFR3-RB1 | [48] | |
| PDAC | miR-192/SIP1 | [50] | |
ALL: acute lymphoblastic leukemia; OS: osteosarcoma; HCC: hepatocellular carcinoma; NB: neuroblastoma; BC: bladder cancer; GC: gastric cancer; NSCLC: non-small-cell lung carcinoma; PDAC: pancreatic ductal adenocarcinoma.